Post COVID-19 vaccination clinical characteristics in a population of health personnel
Article Sidebar
Publicación 2. Vol 6. Num 1.2 (Español (España))
HTML (Español (España))
EPUB (Español (España))
FLIP (Español (España))
Published:
Feb 6, 2023
Keywords:
SARS CoV-2, COVID-19, post vaccination, immunization, pandemic.
Main Article Content
Abstract
Introduction: Adverse events following immunization for COVID-19 in some cases may be masked by probable active SARS CoV-2 infection. Objectives: The objective was to identify the frequency of post-vaccination clinical characteristics in times of pandemic as one of the protective measures in health personnel. Methodology: A database was created in Microsoft Excel 2016, processed with SPSS 25, frequencies and percentages of qualitative and quantitative variables were calculated. Results: It was found that the mean age of the immunized people was 30 years, after the first and second administration of the vaccine the most frequent sign was fever and after the third joint pain. Conclusions: It is important to identify and discriminate between the symptoms of infection versus the post-vaccination symptomatology, to avoid collapses in the emergency area of our hospitals. General area of study: medicine. Specific study area: immunization.
Downloads
Download data is not yet available.
Article Details
How to Cite
Peñaranda Coloma, J. D., Ugarte Vega, M. E., Crespin Rivera, X. S., Intriago Rengifo, E. A., & Pérez Godoy, G. J. (2023). Post COVID-19 vaccination clinical characteristics in a population of health personnel . ConcienciaDigital, 6(1.2), 22-32. https://doi.org/10.33262/concienciadigital.v6i1.2.2474
Section
Artículos
References
Amit, S., Beni, S. A., Biber, A., Grinberg, A., Leshem, E., & Regev-Yochay, G. (2021). Postvaccination COVID-19 among Healthcare Workers, Israel. Emerg Infect Dis. 27(4):1220–2. https://wwwnc.cdc.gov/eid/article /27/4/21-0016_article.htm
Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., & Berry, S. (2021). Articles Risk factors and disease profile of post-vaccination SARS CoV-2 infection in UK users of the COVID. Symptom Study app: a prospective, community-based, nested, case-control study. www.thelancet.com/infectionPubli shedonline
Andrzejczak, G., Grządko, S., Czudy, Z., & Donderska, M. (2021). Efectos secundarios después de las vacunas COVID-19 entre los residentes de Polonia. Revista Europea de Ciencias Médicas y Farmacológicas. P. 4418–4421. https://doi.org/10.26355/eurrev_20210
Becker, M., Balbuena, C., & Samudio, M. (2021). Reacciones adversas post vacunación, y eventual infección por Covid-19 en odontólogos. Revista científica ciencias de la salud p. 85–94. https://doi.org/10.53732/rccsalud/03.02.2021.85
Bhat, S., Tripathi, A., & Kumar, A. (2010). Supermacroprous chitosan-agarose-gelatin cryogels. in vitro characterization and in vivo assesment for cartilage tissue engineering. Journal of the Royal Society Interface, 1-15.
Bossis, G., Marins, J., Kuzhir, P., Volkova, O., & Zubarev, A. (2015). Functionalized microfibers for field-responsive materials and biological applications. Journal of Intelligent Material Systems and Structures, 1-9.
Días, A., Hussain, A., Marcos, A., & Roque, A. (2011). A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides. Biotechnology Advances 29 , 29, 142–155.
Díaz, C., Guanche , & Barbán. (octubre-diciembre de 2021). Recurrencia de infección por COVID-19 en población general inmunizada. Anatomía Digital AD, p. 141-149. SARS-CoV-2/COVID-19: The virus, the disease and the pandemic.: file:///C:/Users/Oficiner/Downloads/1941-Texto%20del%20art%C3%ADculo-8885-1-10-20211203.pdf
Griffin, J. B., Haddix, M., Danza, P., Fisher, R., Koo, T. H., & Traub, E. (2021). SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California. MMWR Morb Mortal Wkly Rep. 27;70(34):1170–6. http://www.cdc.gov/mmwr/volum es/70/wr/mm7034e5.htm?s_cid= mm7034e5_w
Guanche, H., & Barbán , R. (2021). Reinfección, inmunidad y prevención de la transmisión en la COVID-19. Rev haban cienc méd 20(4). http://www.revhabanera.sld.cu/ index.php/rhab/article/view/4101
Keehner, J., Horton, L. E., Pfeffer, M. A., Longhurst, C. A., Schooley, R. T., & Currier, J. S. (2021). SARS-CoV-2 Infection after Vaccination in Health Care Workers in California. N Engl J Med,384(18):1774–5. http://www.nejm.org/doi/10.105 6/NEJMc2101927
Lin, Y.-S., Huang, K.-S., Yang, C.-H., Wang, C.-Y., Yang, Y.-S., Hsu, H.-C., & Tsai, C.-W. (2012). Microfluidic synthesis of microfibers for magnetic-responsive controlled drug release and cell culture. PLoS ONE, 7(3), 1-8.
Oltean, H. N., Allen, K. J., Frisbie, L., Lunn, S. M., Torres, L., Manahan, L. & Lindquist, S. (2023). Implementación y evaluación del sistema de vigilancia centinela para los datos genómicos del SARS-CoV-2, Washington, EE. UU., 2020-2021. Enfermedades infecciosas emergentes, 29(2), 242-251. https://doi.org/10.3201/eid2902.221482.
Organización Mundial de la Salud OMS. (10 de Agosto de 2021). Enfermedad por coronavirus (COVID-19): Investigación y desarrollo de vacunas. https://www.who.int/es/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccine-research-and-development
Song, J., King, S., Yoon , S., Cho, D., & Jeong, Y. (2014). Enhanced spinnability of narbon nanotube fibers by surfactant addition. Fiberes and Polymers, 15(4), 762-766.
Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., & Berry, S. (2021). Articles Risk factors and disease profile of post-vaccination SARS CoV-2 infection in UK users of the COVID. Symptom Study app: a prospective, community-based, nested, case-control study. www.thelancet.com/infectionPubli shedonline
Andrzejczak, G., Grządko, S., Czudy, Z., & Donderska, M. (2021). Efectos secundarios después de las vacunas COVID-19 entre los residentes de Polonia. Revista Europea de Ciencias Médicas y Farmacológicas. P. 4418–4421. https://doi.org/10.26355/eurrev_20210
Becker, M., Balbuena, C., & Samudio, M. (2021). Reacciones adversas post vacunación, y eventual infección por Covid-19 en odontólogos. Revista científica ciencias de la salud p. 85–94. https://doi.org/10.53732/rccsalud/03.02.2021.85
Bhat, S., Tripathi, A., & Kumar, A. (2010). Supermacroprous chitosan-agarose-gelatin cryogels. in vitro characterization and in vivo assesment for cartilage tissue engineering. Journal of the Royal Society Interface, 1-15.
Bossis, G., Marins, J., Kuzhir, P., Volkova, O., & Zubarev, A. (2015). Functionalized microfibers for field-responsive materials and biological applications. Journal of Intelligent Material Systems and Structures, 1-9.
Días, A., Hussain, A., Marcos, A., & Roque, A. (2011). A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides. Biotechnology Advances 29 , 29, 142–155.
Díaz, C., Guanche , & Barbán. (octubre-diciembre de 2021). Recurrencia de infección por COVID-19 en población general inmunizada. Anatomía Digital AD, p. 141-149. SARS-CoV-2/COVID-19: The virus, the disease and the pandemic.: file:///C:/Users/Oficiner/Downloads/1941-Texto%20del%20art%C3%ADculo-8885-1-10-20211203.pdf
Griffin, J. B., Haddix, M., Danza, P., Fisher, R., Koo, T. H., & Traub, E. (2021). SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California. MMWR Morb Mortal Wkly Rep. 27;70(34):1170–6. http://www.cdc.gov/mmwr/volum es/70/wr/mm7034e5.htm?s_cid= mm7034e5_w
Guanche, H., & Barbán , R. (2021). Reinfección, inmunidad y prevención de la transmisión en la COVID-19. Rev haban cienc méd 20(4). http://www.revhabanera.sld.cu/ index.php/rhab/article/view/4101
Keehner, J., Horton, L. E., Pfeffer, M. A., Longhurst, C. A., Schooley, R. T., & Currier, J. S. (2021). SARS-CoV-2 Infection after Vaccination in Health Care Workers in California. N Engl J Med,384(18):1774–5. http://www.nejm.org/doi/10.105 6/NEJMc2101927
Lin, Y.-S., Huang, K.-S., Yang, C.-H., Wang, C.-Y., Yang, Y.-S., Hsu, H.-C., & Tsai, C.-W. (2012). Microfluidic synthesis of microfibers for magnetic-responsive controlled drug release and cell culture. PLoS ONE, 7(3), 1-8.
Oltean, H. N., Allen, K. J., Frisbie, L., Lunn, S. M., Torres, L., Manahan, L. & Lindquist, S. (2023). Implementación y evaluación del sistema de vigilancia centinela para los datos genómicos del SARS-CoV-2, Washington, EE. UU., 2020-2021. Enfermedades infecciosas emergentes, 29(2), 242-251. https://doi.org/10.3201/eid2902.221482.
Organización Mundial de la Salud OMS. (10 de Agosto de 2021). Enfermedad por coronavirus (COVID-19): Investigación y desarrollo de vacunas. https://www.who.int/es/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccine-research-and-development
Song, J., King, S., Yoon , S., Cho, D., & Jeong, Y. (2014). Enhanced spinnability of narbon nanotube fibers by surfactant addition. Fiberes and Polymers, 15(4), 762-766.